These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

446 related items for PubMed ID: 2958623

  • 1. Renal mechanisms of human alpha-atrial natriuretic peptide in man.
    Brown J, Corr L.
    J Physiol; 1987 Jun; 387():31-46. PubMed ID: 2958623
    [Abstract] [Full Text] [Related]

  • 2. Effects of interrupting the renin-angiotensin system on sodium excretion in man.
    Brown J.
    J Physiol; 1988 Jan; 395():17-40. PubMed ID: 3045295
    [Abstract] [Full Text] [Related]

  • 3. Four-hour infusions of synthetic atrial natriuretic peptide in normal volunteers.
    Biollaz J, Nussberger J, Porchet M, Brunner-Ferber F, Otterbein ES, Gomez H, Waeber B, Brunner HR.
    Hypertension; 1986 Jun; 8(6 Pt 2):II96-105. PubMed ID: 2941372
    [Abstract] [Full Text] [Related]

  • 4. Comparison of renal actions of urodilatin and atrial natriuretic peptide.
    Hildebrandt DA, Mizelle HL, Brands MW, Hall JE.
    Am J Physiol; 1992 Mar; 262(3 Pt 2):R395-9. PubMed ID: 1313650
    [Abstract] [Full Text] [Related]

  • 5. Dehydration increases the renal response to atrial natriuretic peptide in fetal sheep.
    Dodd A, Chan K, Kullama LK, Ervin MG, Ross MG.
    Am J Obstet Gynecol; 1992 Dec; 167(6):1710-6. PubMed ID: 1471688
    [Abstract] [Full Text] [Related]

  • 6. Long-term hypotensive and renal effects of atrial natriuretic peptide.
    Granger JP, Opgenorth TJ, Salazar J, Romero JC, Burnett JC.
    Hypertension; 1986 Jun; 8(6 Pt 2):II112-6. PubMed ID: 2941368
    [Abstract] [Full Text] [Related]

  • 7. Differential effects of atrial natriuretic peptide and dopamine on urinary protein excretion in chronic glomerulonephritis.
    Hirata Y, Ishii M, Fukui K, Hayakawa H, Suzuki E, Sugimoto T, Kimura K, Matsuoka H, Sugimoto T.
    Clin Sci (Lond); 1991 Feb; 80(2):131-6. PubMed ID: 1848164
    [Abstract] [Full Text] [Related]

  • 8. Renal and hormonal effects and tolerance of an ANP analogue in healthy man.
    Eiskjaer H, Schmiegelow M, Jespersen B, Tietze IN, Jensen JD, Sørensen SS, Thomsen K, Pedersen EB.
    Eur J Clin Pharmacol; 1991 Feb; 41(6):547-54. PubMed ID: 1840038
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Renal tubular sensitivity to atrial natriuretic factor in essential hypertension.
    Janssen WM, de Zeeuw D, van der Hem GK, de Jong PE.
    J Hypertens; 1994 Apr; 12(4):439-47. PubMed ID: 8064168
    [Abstract] [Full Text] [Related]

  • 11. Effects of sodium intake, furosemide, and infusion of atrial natriuretic peptide on the urinary and metabolic clearances of arginine vasopressin in normal subjects.
    Moses AM, Jones C, Yucha CB.
    J Clin Endocrinol Metab; 1990 Jan; 70(1):222-9. PubMed ID: 2136743
    [Abstract] [Full Text] [Related]

  • 12. Pressure-dependent distal tubular action of atrial natriuretic peptide in healthy humans.
    Eiskjaer H, Nielsen CB, Pedersen EB.
    J Hypertens; 1996 Jan; 14(1):99-106. PubMed ID: 12013501
    [Abstract] [Full Text] [Related]

  • 13. DOPA decarboxylase inhibition does not influence the diuretic and natriuretic response to exogenous alpha-atrial natriuretic peptide in man.
    Kageyama S, Brown J, Causon R, O'Flynn M, Aber V.
    Eur J Clin Pharmacol; 1990 Jan; 38(3):223-7. PubMed ID: 2140325
    [Abstract] [Full Text] [Related]

  • 14. Prazosin attenuates the natriuretic response to atrial natriuretic factor in man.
    Lang CC, Choy AM, Balfour DJ, Struthers AD.
    Kidney Int; 1992 Aug; 42(2):433-41. PubMed ID: 1405327
    [Abstract] [Full Text] [Related]

  • 15. Effects of synthetic human atrial natriuretic peptide (hANP) in conscious dogs.
    Johannessen AC, Schütten HJ, Torp-Pedersen C, Warberg J, Bie P.
    Acta Physiol Scand; 1986 Aug; 127(4):449-54. PubMed ID: 2944353
    [Abstract] [Full Text] [Related]

  • 16. Plasma arginine-vasopressin levels during infusion of synthetic atrial natriuretic peptide on different sodium intakes in man.
    Gnädinger MP, Weidmann P, Rascher W, Lang RE, Hellmüller B, Uehlinger DE.
    J Hypertens; 1986 Oct; 4(5):623-9. PubMed ID: 2947950
    [Abstract] [Full Text] [Related]

  • 17. Enhanced natriuretic effect of atrial natriuretic factor during mineralocorticoid escape in humans.
    Gaillard CA, Koomans HA, Rabelink TJ, Braam B, Boer P, Dorhout Mees EJ.
    Hypertension; 1988 Oct; 12(4):450-6. PubMed ID: 2971618
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The renal action of atrial natriuretic peptide during control of glomerular filtration.
    Burnett JC, Opgenorth TJ, Granger JP.
    Kidney Int; 1986 Jul; 30(1):16-9. PubMed ID: 2943930
    [Abstract] [Full Text] [Related]

  • 20. Atrial natriuretic peptide inhibits osmolality-induced arginine vasopressin release in man.
    Allen MJ, Ang VT, Bennett ED, Jenkins JS.
    Clin Sci (Lond); 1988 Jul; 75(1):35-9. PubMed ID: 2970360
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.